• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后的支架血栓形成:从裸金属支架到最新一代药物洗脱支架。

Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents.

机构信息

Division of Cardiology, Department of Medical and Surgical Sciences, "Magna Graecia" University, Viale Europa, Catanzaro 88100, Italy; Research Center for Cardiovascular Diseases, "Magna Graecia" University, Viale Europa, Catanzaro 88100, Italy.

Division of Cardiology, Department of Medical and Surgical Sciences, "Magna Graecia" University, Viale Europa, Catanzaro 88100, Italy.

出版信息

Cardiol Clin. 2020 Nov;38(4):639-647. doi: 10.1016/j.ccl.2020.07.008. Epub 2020 Sep 17.

DOI:10.1016/j.ccl.2020.07.008
PMID:33036724
Abstract

Since their introduction in clinical practice in 1986, different types of coronary stents have been developed and become available for the treatment of coronary artery disease. Stent thrombosis (ST) is an uncommon but harmful complication after percutaneous coronary implantation, with a high occurrence of acute myocardial infarction and risk of mortality. Among several procedural and clinical predictors, the type of coronary stent is a strong determinant of ST. This article reviews the available evidence on the most used coronary stent types in the modern era and the related risk of ST.

摘要

自 1986 年在临床实践中引入以来,已经开发出不同类型的冠状动脉支架,并可用于治疗冠状动脉疾病。支架血栓形成(ST)是经皮冠状动脉植入后的一种罕见但有害的并发症,可导致急性心肌梗死和死亡风险增加。在几个程序和临床预测因素中,冠状动脉支架的类型是 ST 的一个重要决定因素。本文回顾了现代应用最广泛的几种冠状动脉支架类型的相关证据及其 ST 风险。

相似文献

1
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents.经皮冠状动脉介入治疗后的支架血栓形成:从裸金属支架到最新一代药物洗脱支架。
Cardiol Clin. 2020 Nov;38(4):639-647. doi: 10.1016/j.ccl.2020.07.008. Epub 2020 Sep 17.
2
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents.经皮冠状动脉介入治疗后的支架血栓形成:从裸金属支架到最新一代药物洗脱支架。
Interv Cardiol Clin. 2022 Oct;11(4):465-473. doi: 10.1016/j.iccl.2022.07.002.
3
Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction.COMFORTABLE AMI 试验的 5 年临床结果和冠状动脉影像学研究:急性 ST 段抬高型心肌梗死患者中,载药涂层生物可降解聚合物支架与金属裸支架的随机对照比较。
Eur Heart J. 2019 Jun 21;40(24):1909-1919. doi: 10.1093/eurheartj/ehz074.
4
Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].第二代药物洗脱支架与裸金属支架治疗 ST 段抬高型心肌梗死的支架血栓形成:直接经皮冠状动脉介入治疗临床试验的网络荟萃分析 [更正]。
Circ Cardiovasc Interv. 2014 Feb;7(1):49-61. doi: 10.1161/CIRCINTERVENTIONS.113.000412. Epub 2013 Nov 26.
5
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.与含有不可降解聚合物的西罗莫司洗脱支架相比,含可生物降解聚合物的比伐卢定洗脱支架在冠状动脉疾病患者中具有更好的安全性和降低支架血栓形成的风险:LEADERS(雷帕霉素从不可降解到可降解涂层支架洗脱)随机、非劣效性试验的最终 5 年报告。
JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. doi: 10.1016/j.jcin.2013.04.011.
6
Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.比较新一代药物洗脱支架和裸金属支架在急性 ST 段抬高型心肌梗死患者中的应用:EXAMINATION(急性心肌梗死中评价 Xience-V 支架的临床研究)和 COMFORTABLE-AMI(急性 ST 段抬高型心肌梗死中生物可降解涂层雷帕霉素洗脱支架与裸金属支架的比较研究)试验的汇总分析。
JACC Cardiovasc Interv. 2014 Jan;7(1):55-63. doi: 10.1016/j.jcin.2013.07.012. Epub 2013 Dec 11.
7
Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.裸金属支架、第一代药物洗脱支架和第二代药物洗脱支架的支架血栓形成风险:来自 18334 名患者的注册研究结果。
JACC Cardiovasc Interv. 2013 Dec;6(12):1267-74. doi: 10.1016/j.jcin.2013.06.015.
8
Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.与裸金属支架相比,第二代药物洗脱支架的极晚期支架内血栓形成:随机原发性经皮冠状动脉介入试验的网状荟萃分析
Catheter Cardiovasc Interv. 2016 Jul;88(1):38-48. doi: 10.1002/ccd.26458. Epub 2016 Feb 24.
9
Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.在 ST 段抬高型心肌梗死患者中,不同药物洗脱支架或金属裸支架的结局:来自随机试验 34068 患者年随访的试验水平数据的混合治疗比较分析。
Circ Cardiovasc Interv. 2013 Aug;6(4):378-90. doi: 10.1161/CIRCINTERVENTIONS.113.000415. Epub 2013 Aug 6.
10
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).药物洗脱支架与金属裸支架置入治疗 ST 段抬高型心肌梗死患者的长期疗效:DEDICATION 试验(急性心肌梗死中药物洗脱和远端保护)的 5 年随访结果
JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15.

引用本文的文献

1
Enhanced Hemocompatibility and Cytocompatibility of Stainless Steel.不锈钢增强的血液相容性和细胞相容性。
ACS Omega. 2024 Apr 16;9(17):19566-19577. doi: 10.1021/acsomega.4c01191. eCollection 2024 Apr 30.
2
Polymer-Drug Anti-Thrombogenic and Hemocompatible Coatings as Surface Modifications.作为表面改性的聚合物-药物抗血栓形成和血液相容性涂层
Pharmaceutics. 2024 Mar 21;16(3):432. doi: 10.3390/pharmaceutics16030432.
3
Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis.基于文献计量分析视角的冠状动脉疾病药物洗脱支架研究
Front Cardiovasc Med. 2024 Feb 19;11:1288659. doi: 10.3389/fcvm.2024.1288659. eCollection 2024.
4
Effect of ticagrelor and clopidogrel dual antiplatelet therapy on MPVLR, MAADP, and AA inhibition rate in acute coronary syndrome patients after percutaneous coronary intervention.替格瑞洛和氯吡格雷双联抗血小板治疗对经皮冠状动脉介入治疗后急性冠状动脉综合征患者血小板平均体积与血小板容积比、最大血小板聚集率和花生四烯酸抑制率的影响。
Medicine (Baltimore). 2023 Sep 15;102(37):e34974. doi: 10.1097/MD.0000000000034974.
5
Anti-inflammatory Therapy Progress in Major Adverse Cardiac Events after PCI: Chinese and Western Medicine.经皮冠状动脉介入治疗(PCI)后主要不良心脏事件的抗炎治疗进展:中西医结合。
Chin J Integr Med. 2023 Jul;29(7):655-664. doi: 10.1007/s11655-023-3638-8. Epub 2023 May 18.
6
Drug-Eluting Stents: Technical and Clinical Progress.药物洗脱支架:技术与临床进展
Biomimetics (Basel). 2023 Feb 9;8(1):72. doi: 10.3390/biomimetics8010072.
7
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence.当代药物洗脱支架的支架内血栓形成与再狭窄:预测因素及当前证据
J Clin Med. 2023 Feb 3;12(3):1238. doi: 10.3390/jcm12031238.
8
Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations.抗动脉粥样硬化治疗:里程碑、挑战和新兴创新。
Mol Ther. 2022 Oct 5;30(10):3106-3117. doi: 10.1016/j.ymthe.2022.08.024. Epub 2022 Sep 5.
9
Effectiveness of Direct Laser Interference Patterning and Peptide Immobilization on Endothelial Cell Migration for Cardio-Vascular Applications: An In Vitro Study.直接激光干涉图案化和肽固定对心血管应用中内皮细胞迁移的有效性:一项体外研究
Nanomaterials (Basel). 2022 Apr 5;12(7):1217. doi: 10.3390/nano12071217.
10
Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.依维莫司洗脱支架与佐他莫司洗脱支架在接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者中的五年疗效比较
J Clin Med. 2021 Mar 19;10(6):1278. doi: 10.3390/jcm10061278.